5 October 2020

Allen & Gledhill advised SoftBank Vision Fund II, as transaction counsel, which led the US$100 million Series C investment (“Investment”) in Biofourmis Holdings Pte. Ltd., a health start-up that combines artificial intelligence-based data analytics and biosensors to monitor the progress of medical treatments.

The Investment is a significant milestone in the growth of Biofourmis which develops artificial intelligence-powered digital therapeutic solutions to enhance conventional health services.

Advising SoftBank Vision Fund II were Allen & Gledhill Partners Christian Chin, Eugene Ho and Tan Kai Liang.

More

A&G News 11 September 2025

Allen & Gledhill named FinTech and Digital Assets Firm of the Year at the Asia Legal Awards 2025

Read more

A&G News 25 August 2025

A&G Asia recognised in Lexology Index’s Southeast Asia 2025 guide

Read more